These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 3879684)

  • 61. [The pediatric vaccination counseling facility].
    Wiersbitzky S; Bruns R
    Kinderarztl Prax; 1989 Jun; 57(6):295-6. PubMed ID: 2788768
    [No Abstract]   [Full Text] [Related]  

  • 62. [Detection of tolerance to diphtheria-pertussis-tetanus vaccines].
    Künzel W; Meissner C; Lüderitz U; Willkommen H; Winkler C
    Padiatr Grenzgeb; 1986; 25(2-3):197-203. PubMed ID: 3523392
    [No Abstract]   [Full Text] [Related]  

  • 63. Fractional doses of DPT vaccine.
    Hankins CA
    Can Med Assoc J; 1985 Jan; 132(2):96-7. PubMed ID: 3871169
    [No Abstract]   [Full Text] [Related]  

  • 64. Half-dose immunization for diphtheria, tetanus, pertussis: response of preterm infants.
    Bernbaum J; Daft A; Samuelson J; Polin RA
    Pediatrics; 1989 Apr; 83(4):471-6. PubMed ID: 2538797
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pertussis immunization.
    Simon FA
    Pediatrics; 1979 Sep; 64(3):387-8. PubMed ID: 481986
    [No Abstract]   [Full Text] [Related]  

  • 66. Minor adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study Group.
    Schmitt-Grohé S; Stehr K; Cherry JD; Heininger U; Uberall MA; Laussucq S; Eckhardt T
    Dev Biol Stand; 1997; 89():113-8. PubMed ID: 9272341
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Adverse reactions of a pertussis toxoid vaccine in a double-blind placebo-controlled trial.
    Taranger J; Trollfors B; Knutsson N
    Dev Biol Stand; 1997; 89():109-12. PubMed ID: 9272340
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Several complications after immunization with associated whooping cough-diphtheria-tetanus, antimeasles and antipoliomyelitis vaccines].
    Bondarev VN; Dadiomova MA; Pratusevich RM
    Pediatriia; 1968 Nov; 47(11):26-9. PubMed ID: 5721342
    [No Abstract]   [Full Text] [Related]  

  • 69. [A pediatric vaccination counseling service].
    Wiersbitzky S; Scholz H; Baumann S
    Kinderarztl Prax; 1988 Nov; 56(11):557-8. PubMed ID: 3264863
    [No Abstract]   [Full Text] [Related]  

  • 70. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
    Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
    Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Anti-whooping cough vaccination. Contribution of a case series].
    Borselli L; Giraldi P
    Minerva Pediatr; 1988 Feb; 40(2):91-7. PubMed ID: 3260328
    [No Abstract]   [Full Text] [Related]  

  • 72. Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.
    Lee SY; Hwang HS; Kim JH; Kim HH; Lee HS; Chung EH; Park SE; Ma SH; Chang JK; Guitton F; Ortiz E; Kang JH
    Vaccine; 2011 Feb; 29(8):1551-7. PubMed ID: 21215828
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Diphtheria-tetanus-pertussis immunization and sudden infant death: results of the National Institute of Child Health and Human Development Cooperative Epidemiological Study of Sudden Infant Death Syndrome risk factors.
    Hoffman HJ; Hunter JC; Damus K; Pakter J; Peterson DR; van Belle G; Hasselmeyer EG
    Pediatrics; 1987 Apr; 79(4):598-611. PubMed ID: 3493477
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Bias in evaluating CNS complications following pertussis immunization.
    Ehrengut W
    Acta Paediatr Jpn; 1991 Aug; 33(4):421-7. PubMed ID: 1792899
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Permanent brain damage and pertussis vaccination: is the end of the saga in sight?
    Griffith AH
    Vaccine; 1989 Jun; 7(3):199-210. PubMed ID: 2571213
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pertussis immunisation and serious acute neurological illnesses in children.
    Miller D; Madge N; Diamond J; Wadsworth J; Ross E
    BMJ; 1993 Nov; 307(6913):1171-6. PubMed ID: 7504540
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pertussis and pertussis vaccine: further analysis of benefits, risks and costs.
    Hinman AR; Koplan JP
    Dev Biol Stand; 1985; 61():429-37. PubMed ID: 3938968
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Whooping cough in Fiji.
    Pollard R
    Lancet; 1983 Jun; 1(8338):1381. PubMed ID: 6134156
    [No Abstract]   [Full Text] [Related]  

  • 79. Pertussis immunisation and serious acute neurological illness in children.
    Miller DL; Ross EM; Alderslade R; Bellman MH; Rawson NS
    Br Med J (Clin Res Ed); 1981 May; 282(6276):1595-9. PubMed ID: 6786580
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Clinical analysis of 247 children with whooping cough and the risk factors of severe cases].
    Hu Y; Liu Q
    Zhonghua Er Ke Za Zhi; 2015 Sep; 53(9):684-9. PubMed ID: 26757969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.